Your session is about to expire
What is Selzentry
MaravirocThe Generic name of this drug
Treatment SummaryMaraviroc (also known as Selzentry or Celsentri) is an HIV drug created by Pfizer. It works by blocking the interaction between HIV and the CCR5 protein. It was originally called UK-427857 during development but was eventually called Maraviroc. It was approved by the FDA in 2007.
Selzentryis the brand name
Selzentry Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Selzentry
Maraviroc
2007
17
Approved as Treatment by the FDA
Maraviroc, commonly known as Selzentry, is approved by the FDA for 1 uses which include HIV .HIV
Used to treat Human Immunodeficiency Virus Type 1 (HIV-1) Infection in combination with null
Effectiveness
How Selzentry Affects PatientsMaraviroc is a medicine made by Pfizer that is designed to fight HIV. It works by blocking the connection between HIV and a receptor called CCR5.
How Selzentry works in the bodyMaraviroc is a drug that stops HIV from entering cells. It specifically targets the CCR5 receptor, which is a molecule on the surface of T-cells, and binds to it. This binding prevents HIV from using the receptor to enter the cell, which stops it from replicating.
When to interrupt dosage
The measure of Selzentry is contingent upon the recognized affliction. The amount of dosage fluctuates in relation to the technique of delivery featured in the table beneath.Condition
Dosage
Administration
Antiretroviral Therapy
, 150.0 mg, 300.0 mg, 25.0 mg, 75.0 mg, 20.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral
HIV
, 150.0 mg, 300.0 mg, 25.0 mg, 75.0 mg, 20.0 mg/mL
, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral
Warnings
There are 15 known major drug interactions with Selzentry.Common Selzentry Drug Interactions
Drug Name
Risk Level
Description
Pexidartinib
Major
Maraviroc may increase the hepatotoxic activities of Pexidartinib.
Adenovirus type 7 vaccine live
Moderate
The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Maraviroc.
Anthrax vaccine
Moderate
The therapeutic efficacy of Anthrax vaccine can be decreased when used in combination with Maraviroc.
BCG vaccine
Moderate
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Maraviroc.
Bacillus calmette-guerin substrain connaught live antigen
Moderate
The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Maraviroc.
Selzentry Novel Uses: Which Conditions Have a Clinical Trial Featuring Selzentry?
43 active studies are underway to examine the efficacy of Selzentry as a potential treatment for HIV (Human Immunodeficiency Virus).Condition
Clinical Trials
Trial Phases
HIV
44 Actively Recruiting
Phase 2, Phase 3, Early Phase 1, Phase 1, Not Applicable, Phase 4
Antiretroviral Therapy
0 Actively Recruiting
Patient Q&A Section about selzentry
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.Is selzentry generic?
"is the date when Camber Pharmaceuticals will release their AB-rated generic version of ViiV Healthcare's Selzentry."
Answered by AI
What is selzentry used for?
"A prescription medicine called Maraviroc, sold under the brand name Selzentry, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV infection in adults and children weighing at least 4.4 lb (2 kg). Maraviroc must always be used in combination with other HIV medicines."
Answered by AI
Who manufactures selzentry?
"Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Selzentry TM (maraviroc) tablets, the first in a new class of oral HIV medicines in more than 10 years."
Answered by AI